IZAKOVIČOVÁ HOLLÁ, Lydie, František MRÁZEK and Martin PETŘEK. MCP-1 and CCR2 gene polymorphisms in Czech patients with allergic disorders. Int J Immunogenet. Anglie: Blackwell, 2009, vol. 36, No 1, p. 69-72. ISSN 1744-3121.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name MCP-1 and CCR2 gene polymorphisms in Czech patients with allergic disorders
Name in Czech MCP-1 a CCR2 genové polymorfizmy u českých pacientů s alergickými chorobami
Authors IZAKOVIČOVÁ HOLLÁ, Lydie (203 Czech Republic, guarantor), František MRÁZEK (203 Czech Republic) and Martin PETŘEK (203 Czech Republic).
Edition Int J Immunogenet, Anglie, Blackwell, 2009, 1744-3121.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30300 3.3 Health sciences
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.522
RIV identification code RIV/00216224:14110/09:00029107
Organization unit Faculty of Medicine
UT WoS 000262667000010
Keywords in English Allergy; CCR2; gene; MCP-1; polymorphism
Tags allergy, CCR2, gene, MCP-1, polymorphism
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Lydie Izakovičová Hollá, Ph.D., učo 734. Changed: 17/6/2009 11:11.
Abstract
Several lines of evidence suggest that chemokines play an important role in asthma and allergy. We analyzed polymorphisms at -2518A/G and -2076A/T of MCP-1 and V64I of CCR2 gene in healthy subjects (n=306) and allergic patients (n=332). Allele and genotype frequencies did not differ significantly between groups. Nevertheless, MCP-1 variants were associated with allergen sensitization. The results suggest that MCP-1, but not CCR2 gene variants, may participate in the pathogenesis of allergic phenotypes at least in the Caucasian population.
Abstract (in Czech)
Řada studií naznačuje důležitou úlohu chemokinů u astmatu a alergických stavů. V práci jsme analyzovali polymorfizmy v pozici -2518A/G a -2076A/T v genu pro MCP-1 a V64I v genu pro CCR2 u zdravých osob (n=306) a alergických pacientů (n=332). Neprokázali jsme rozdíly ve frekvencíchc alel nebo genotypů mezi oběma skupinami. Naproti tomu, MCP-1 varianty byly asociovány se senzitizací na určité alergeny. Naše výsledky naznačují, že MCP-1, ale ne CCR2 genové polymorfizmy mohou participovat v patogenezi alergických fenotypů, přinejmenším v naší populaci.
Links
GA310/06/0827, research and development projectName: Genetické determinanty pro-/antioxidační rovnováhy v patogeneze respiračních nemocí
Investor: Czech Science Foundation
PrintDisplayed: 28/4/2024 00:51